• Epistaxis
  • Dopamine receptor 2 (DRD2) Genotyping
  • Metanephrines, Fractionated, Random, Urine
  • Cyclin-Dependent Kinase-Like 5 (CDKL5) Mutation Analysis
  • Leishmania (Visceral Leishmaniasis) Antibody, IgG
  • Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
  • Venous Blood Gases
  • Circulating Tumor Cells (CTC), Colon Cancer
  • Trypanosoma cruzi (T. cruzi) Antibody, IgM
  • JAK2 (V617F) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /DetermaRx for Lung Cancer Disease Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

DetermaRx for Lung Cancer Disease Management
Medical Test

LOINC
Access to DetermaRx for Lung Cancer Disease Management is restricted.
Loading...